Furthermore, we showed that changing the expression of HDAC8 or treated PCI‐34051 regulated the anticancer effect of a HIF‐2α inhibitor (PT2385) on ccRCC cells (Figure 5Q,R; Figure S4F, Supporting Information). The gene discussed is HDAC8; the disease is nonpapillary renal cell carcinoma.